Skip to content
The Policy VaultThe Policy Vault

Namenda tabletsCigna

moderate to severe dementia of the Alzheimer’s type

Preferred products

  • generic memantine tablets
  • generic memantine oral solution

Initial criteria

  • Patient has tried one Step 1 Product (generic memantine tablets OR generic memantine oral solution)

Approval duration

1 year